Copper and anesthesia: Clinical relevance and management of copper related disorders

Anesthesiology Research and Practice

Volumn 2013, Issue , 2013, Pages

  Langley, Adrian ^a   Dameron, Charles T ^b  

^a QUEEN ELIZABETH II JUBILEE HOSPITAL   (Australia)

^b SAINT FRANCIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE 7A; ADVANCED GLYCATION END PRODUCT; ALPHA AMIDATING ENZYME; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BENZODIAZEPINE; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CALCITONIN; CERULOPLASMIN; CHOLECYSTOKININ; COPPER; COPPER CHLORIDE; COPPER ZINC SUPEROXIDE DISMUTASE; CORTICOTROPIN RELEASING FACTOR; DOPAMINE BETA MONOOXYGENASE; GASTRIN; GLUTATHIONE; HISTIDINE COPPER; HISTIDINE DERIVATIVE; INTERLEUKIN 2; LYSL OXIDASE; METALLOTHIONEIN; N ACETYL BETA GLUCOSAMINIDASE; N METHYL DEXTRO ASPARTIC ACID; OXIDOREDUCTASE; OXYTOCIN; PROTIRELIN; UNCLASSIFIED DRUG; VASOPRESSIN;

ACUTE KIDNEY FAILURE; AMYOTROPHIC LATERAL SCLEROSIS; ANESTHESIA; COPPER BLOOD LEVEL; COPPER DEFICIENCY; COPPER METABOLISM; DETOXIFICATION; ENZYME ACTIVITY; GENE MUTATION; GENERAL ANESTHESIA; HEMOLYTIC ANEMIA; HEPATOPULMONARY SYNDROME; HUMAN; HUNTINGTON CHOREA; MENKES SYNDROME; MUSCLE HYPOTONIA; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PORTOPULMONARY HYPERTENSION; PREGNANCY; PRION DISEASE; PRIORITY JOURNAL; PROTEIN INTERACTION; PUERPERAL DEPRESSION; REVIEW; URINARY EXCRETION; WILSON DISEASE;

EID: 84878668868     PISSN: 16876962     EISSN: 16876970     Source Type: Journal    
DOI: 10.1155/2013/750901     Document Type: Review

References (94)

1. Fraga C. G., Relevance, essentiality and toxicity of trace elements in human health. Molecular Aspects of Medicine 2005 26 4-5 235 244 2-s2.0-24044480992 10.1016/j.mam.2005.07.013 (Pubitemid 41225351)
2. Itoh S., Ha W. K., Nakagawa O., Ozumi K., Lessner S. M., Aoki H., Akram K., McKinney R. D., Ushio-Fukai M., Fukai T., Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation. Journal of Biological Chemistry 2008 283 14 9157 9167 2-s2.0-44049091591 10.1074/jbc.M709463200
3. Boyuk A., Banli O., Gumus M., Plasma levels of zinc, copper, and ceruloplasmin in patients after undergoing laparoscopic adjustable gastric banding. Biological Trace Element Research 2011 143 3 1282 1288 10.1007/s12011-011-8965-5
4. Beshgetoor D., Hambidge M., Clinical conditions altering copper metabolism in humans. American Journal of Clinical Nutrition 1998 67 5 1017S 1021S 2-s2.0-0031960876 (Pubitemid 28198826)
5. Stern B. R., Solioz M., Krewski D., Aggett P., Aw T. C., Baker S., Crump K., Dourson M., Haber L., Hertzberg R., Keen C., Meek B., Rudenko L., Schoeny R., Slob W., Starr T., Copper and human health: biochemistry, genetics, and strategies for modeling dose-response relationships. Journal of Toxicology and Environmental Health B 2007 10 3 157 222 2-s2.0-34047134537 10.1080/ 10937400600755911 (Pubitemid 46514929)
6. Cockell K. A., Bertinato J., L'Abbé M. R., Regulatory frameworks for copper considering chronic exposures of the population. American Journal of Clinical Nutrition 2008 88 3 863S 866S 2-s2.0-51749122676
7. Barceloux D. G., Copper. Journal of Toxicology 1999 37 2 217 230 10.1081/CLT-100102421 (Pubitemid 29292908)
8. Wapnir R. A., Copper absorption and bioavailability. American Journal of Clinical Nutrition 1998 67 supplement 5 1054S 1060S (Pubitemid 28198832)
9. Arredondo M., Nunez M. T., Iron and copper metabolism. Molecular Aspects of Medicine 2005 26 4-5 313 327 10.1016/j.mam.2005.07.010 (Pubitemid 41225355)
10. van den Berghe P. V. E., Klomp L. W. J., New developments in the regulation of intestinal copper absorptionn. Nutrition Reviews 2009 67 11 658 672 2-s2.0-74949100486 10.1111/j.1753-4887.2009.00250.x
11. Kehrer J. P., The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 2000 149 1 43 50 2-s2.0-0034648298 10.1016/S0300-483X(00)00231-6 (Pubitemid 30645786)
12. Prohaska J. R., Biochemical changes in copper deficiency. Journal of Nutritional Biochemistry 1990 1 9 452 461 10.1016/0955-2863(90)90080-5 (Pubitemid 20328386)
13. Dameron C. T., Harrison M. D., Mechanisms for protection against copper toxicity. American Journal of Clinical Nutrition 1998 67 5 1091S 1097S 2-s2.0-0031960981 (Pubitemid 28198839)
14. McArdle H. J., Andersen H. S., Jones H., Gambling L., Copper and iron transport across the placenta: regulation and interactions. Journal of Neuroendocrinology 2008 20 4 427 431 2-s2.0-41149120285 10.1111/j.1365-2826. 2008.01658.x (Pubitemid 351437029)
15. Kaler S. G., Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency. American Journal of Clinical Nutrition 1998 67 5 1029S 1034S 2-s2.0-0031980440 (Pubitemid 28198828)
16. Kirodian B. C., Gogtay N. J., Udani V. P., Kshirsagar N. A., Treatment of menkes disease with parenteral copper histidine. Indian Pediatrics 2002 39 2 183 185 2-s2.0-0036182229 (Pubitemid 34171036)
17. Roberts E. A., Sarkar B., Liver as a key organ in the supply, storage, and excretion of copper. American Journal of Clinical Nutrition 2008 88 3 851S 584S 2-s2.0-51749111418
18. Ala A., Walker A. P., Ashkan K., Dooley J. S., Schilsky M. L., Wilson's disease. The Lancet 2007 369 9559 397 408 2-s2.0-33846582913 10.1016/S0140-6736(07)60196-2 (Pubitemid 46177228)
19. Brewer G. J., Recognition, diagnosis, and management of Wilson's disease. Proceedings of the Society for Experimental Biology and Medicine 2000 223 1 39 46 10.1046/j.1525-1373.2000.22305.x (Pubitemid 30182655)
20. Milne D. B., Copper intake and assessment of copper status. American Journal of Clinical Nutrition 1998 67 5 1041S 1045S 2-s2.0-0031959842 (Pubitemid 28198830)
21. Iakovidis I., Delimaris I., Piperakis S. M., Copper and its complexes in medicine: a biochemical approach. Molecular Biology International 2011 2011 13 594529 10.4061/2011/594529
22. Olivares M., Mendez M. A., Astudillo P. A., Present situation of biomarkers for copper status. American Journal of Clinical Nutrition 2008 88 3 859S 862S
23. Kaler S. G., Holmes C. S., Goldstein D. S., Tang J., Godwin S. C., Donsante A., Liew C. J., Sato S., Patronas N., Neonatal diagnosis and treatment of Menkes disease. New England Journal of Medicine 2008 358 6 605 614 2-s2.0-38949106566 10.1056/NEJMoa070613 (Pubitemid 351214287)
24. Arnon R., Calderon J. F., Schilsky M., Emre S., Shneider B. L., Wilson disease in children: serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine) treatment. Journal of Pediatric Gastroenterology and Nutrition 2007 44 5 596 602 2-s2.0-34247634026 10.1097/MPG.0b013e3180467715 (Pubitemid 46684362)
25. Sözeri E., Feist D., Ruder H., Schärer K., Proteinuria and other renal functions in Wilson's disease. Pediatric Nephrology 1997 11 3 307 311 2-s2.0-0030907559 10.1007/s004670050282 (Pubitemid 27230813)
26. Roberts E. A., Schilsky M. L., Diagnosis and treatment of Wilson disease: an update. Hepatology 2008 47 6 2089 2111 2-s2.0-46249112793 10.1002/hep.22261 (Pubitemid 351945575)
27. Madsen E., Gitlin J. D., Copper and iron disorders of the brain. Annual Review of Neuroscience 2007 30 317 337 2-s2.0-34547782810 10.1146/annurev.neuro. 30.051606.094232 (Pubitemid 47224759)
28. Aedo F., Delgado R., Wolff D., Vergara C., Copper and zinc as modulators of neuronal excitability in a physiologically significant concentration range. Neurochemistry International 2007 50 4 591 600 2-s2.0-33847330777 10.1016/j.neuint.2006.12.001 (Pubitemid 46329830)
29. Delgado R., Vergara C., Wolff D., Divalent cations as modulators of neuronal excitability: emphasis on copper and zinc. Biological Research 2006 39 1 173 182 2-s2.0-33745819895 (Pubitemid 44027658)
30. Liu H. T., Hollmann M. W., Liu W. H., Hoenemann C. W., Durieux M. E., Modulation of NMDA receptor function by ketamine and magnesium: part I. Anesthesia and Analgesia 2001 92 5 1173 1181 2-s2.0-0035035663 (Pubitemid 32385939)
31. Schlief M. L., Gitlin J. D., Copper homeostasis in the CNS: a novel link between the NMDA receptor and copper homeostasis in the hippocampus. Molecular Neurobiology 2006 33 2 81 90 2-s2.0-33646856612 10.1385/MN:33:2:81 (Pubitemid 43780368)
32. Lutsenko S., Bhattacharjee A., Hubbard A. L., Copper handling machinery of the brain. Metallomics 2010 2 9 596 608 2-s2.0-77956330693 10.1039/c0mt00006j
33. Desai V., Kaler S. G., Role of copper in human neurological disorders. American Journal of Clinical Nutrition 2008 88 3 855S 888S 2-s2.0-51749108879
34. Tan J. C., Burns D. L., Jones H. R., Severe ataxia, myelopathy, and peripheral neuropathy due to acquired copper deficiency in a patient with history of gastrectomy. Journal of Parenteral and Enteral Nutrition 2006 30 5 446 450 2-s2.0-33749254859 10.1177/0148607106030005446
35. Kumar N., Copper deficiency myelopathy (human swayback). Mayo Clinic Proceedings 2006 81 10 1371 1384 2-s2.0-33749235493 10.4065/81.10.1371 (Pubitemid 44484976)
36. Saari J. T., Schuschke D. A., Cardiovascular effects of dietary copper deficiency. BioFactors 1999 10 4 359 375 2-s2.0-0032733673
37. Hicks J. D., Donsante A., Pierson T. M., Increased frequency of congenital heart defects in Menkes disease. Clinical Dysmorphology 2012 21 2 59 63 10.1097/MCD.0b013e32834ea52b
38. Hlubocka Z., Marecek Z., Linhart A., Cardiac involvement in Wilson disease. Journal of Inherited Metabolic Disease 2002 25 4 269 277 10.1023/A:1016546223327 (Pubitemid 34987475)
39. Zhang S. T., Li X. G., Liu C. H., Effects of copper chloride on electromechanical activities of myocardial cells. Zhongguo Yao Li Xue Bao 1990 11 166 168
40. Qi Y. F., Che X. P., Effects of Cu2+ on the neuromuscular junction transmission. Acta Pharmaceutica Sinica 1992 27 2 81 85 2-s2.0-0026620136
41. Prasun N., Bagchi M., Joseph A., Pal S., Ghosh S., Mukherjee S., Senapati A. K., Das S. K., Recurrent bleeding and bulbar myasthenia-like symptoms as the initial presentation of Wilson's disease: a case report. Neurology Asia 2011 16 2 167 169 2-s2.0-79960514633
42. Agertt F., Crippa A. C. S., Lorenzoni P. J., Scola R. H., Bruck I., De Paola L., Silvado C. E., Werneck L. C., Menkes' disease: case report. Arquivos de Neuro-Psiquiatria 2007 65 1 157 160 2-s2.0-34147105442 10.1590/S0004- 282X2007000100032 (Pubitemid 46569551)
43. Zhang L., Lv J., Sun S., Elements in lung tissues of patients from a high lung cancer incidence area of China. Biological Trace Element Research 2012 148 1 7 10
44. Tanrikulu A. C., Abakay A., Evliyaoglu O., Coenzyme Q10, copper, zinc, and lipid peroxidation levels in serum of patients with chronic obstructive pulmonary disease. Biological Trace Element Research 2011 143 2 659 667 10.1007/s12011-010-8897-5
45. Kinnula V. L., Crapo J. D., Superoxide dismutases in the lung and human lung diseases. American Journal of Respiratory and Critical Care Medicine 2003 167 12 1600 1619 2-s2.0-0038545583 10.1164/rccm.200212-1479SO (Pubitemid 36760673)
46. Mizuno S., Yasuo M., Bogaard H. J., Copper deficiency induced emphysema is associated with focal adhesion kinase inactivation. PLoS One 2012 7 e30678
47. Tobias J. D., Anaesthetic considerations in the child with Menkes' syndrome. Canadian Journal of Anaesthesia 1992 39 7 712 715 2-s2.0-0026674676
48. Passariello M., Almenrader N., Pietropaoli P., Anesthesia for a child with Menkes disease. Paediatric Anaesthesia 2008 18 12 1225 1226 2-s2.0-55149116938 10.1111/j.1460-9592.2008.02716.x
49. de Souza Hobaika A. B., Anesthesia for a patient with Wilson's disease-a case report. Middle East Journal of Anesthesiology 2008 19 4 905 908 2-s2.0-43149104381
50. Baykal M., Karapolat S., Anesthetic management of a pediatric patient with wilsons disease. Journal of Clinical Medicine Research 2010 2 2 99 101
51. Vaja R., McNicol L., Sisley I., Anaesthesia for patients with liver disease. Continuing Education in Anaesthesia, Critical Care and Pain 2009 10 1 15 19 2-s2.0-77956562602 10.1093/bjaceaccp/mkp040 mkp040
52. Narayanan P., Chetan G., Mahadevan S., Wilson's disease presenting as respiratory failure. Indian Journal of Pediatrics 2006 73 1 99 100 2-s2.0-33745960758 10.1007/BF02758271 (Pubitemid 44323886)
53. Mandell M. S., Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era. Liver Transplantation 2004 10 10 S54 S58 2-s2.0-6444227185 10.1002/lt.20260 (Pubitemid 39406101)
54. Percival S. S., Copper and immunity. American Journal of Clinical Nutrition 1998 67 supplement 5 1064S 1068S (Pubitemid 28198834)
55. Bonham M., O'Connor J. M., Hannigan B. M., Strain J. J., The immune system as a physiological indicator of marginal copper status? British Journal of Nutrition 2002 87 5 393 403 2-s2.0-0036265053 (Pubitemid 34575561)
56. White C., Lee J., Kambe T., Fritsche K., Petris M. J., A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. Journal of Biological Chemistry 2009 284 49 33949 33956 2-s2.0-71749115454 10.1074/jbc.M109.070201
57. Turnlund J. R., Jacob R. A., Keen C. L., Strain J. J., Kelley D. S., Domek J. M., Keyes W. R., Ensunsa J. L., Lykkesfeldt J., Coulter J., Long-term high copper intake: effects on indexes of copper status, antioxidant status, and immune function in young men. American Journal of Clinical Nutrition 2004 79 6 1037 1044 2-s2.0-3042847439 (Pubitemid 41095956)
58. Czlonkowska A., Milewski B., Immunological observations on patients with Wilson's disease. Journal of the Neurological Sciences 1976 29 2-4 411 421 2-s2.0-0017187205
59. Milkiewicz P., Saksena S., Hubscher S. G., Elias E., Wilson's disease with superimposed autoimmune features: report of two cases and review. Journal of Gastroenterology and Hepatology 2000 15 5 570 574 2-s2.0-0034036966 10.1046/j.1440-1746.2000.02158.x (Pubitemid 30327064)
60. Santos R. G., Alissa F., Reyes J., Teot L., Ameen N. A., Fulminant hepatic failure: Wilson's disease or autoimmune hepatitis? Implications for transplantation. Pediatric Transplantation 2005 9 1 112 116 2-s2.0-13744255815 10.1111/j.1399-3046.2005.00254.x (Pubitemid 40238975)
61. Imataki O., Ohnishi H., Kitanaka A., Kubota Y., Ishida T., Tanaka T., Pancytopenia complicated with peripheral neuropathy due to copper deficiency: clinical diagnostic review. Internal Medicine 2008 47 23 2063 2065 2-s2.0-61749101933 10.2169/internalmedicine.47.1323
62. Sharma S., Toppo A., Rath B., Harbhajanka A., Lalita Jyotsna P., Hemolytic anemia as a presenting feature of wilson's disease: a case report. Indian Journal of Hematology and Blood Transfusion 2010 26 3 101 102 2-s2.0-78650543844 10.1007/s12288-010-0034-2
63. Adams K. F., Johnson G. Jr., Hornowski K. E., Lineberger T. H., The effect of copper on erythrocyte deformability. A possible mechanism of hemolysis in acute copper intoxication. Biochim Biophys Acta 1979 550 2 279 287 2-s2.0-0018795371
64. Cooper G. J. S., Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and alzheimers disease. Drugs 2011 71 10 1281 1320 2-s2.0-79960497233 10.2165/11591370-000000000-00000
65. Goh S. Y., Cooper M. E., The role of advanced glycation end products in progression and complications of diabetes. Journal of Clinical Endocrinology and Metabolism 2008 93 4 1143 1152 2-s2.0-42049118293 10.1210/jc.2007-1817 (Pubitemid 351519698)
66. Linz R., Barnes N. L., Zimnicka A. M., Kaplan J. H., Eipper B., Lutsenko S., Intracellular targeting of copper-transporting ATPase ATP7A in a normal and Atp7b-/- kidney. American Journal of Physiology 2008 294 1 F53 F61 2-s2.0-38349016602 10.1152/ajprenal.00314.2007
67. Zhuang X. H., Mo Y., Jiang X. Y., Analysis of renal impairment in children with Wilson's disease. World Journal of Pediatrics 2008 4 2 102 105 10.1007/s12519-008-0019-5 (Pubitemid 351736693)
68. Sondheimer J. H., Mahajan S. K., Rye D. L., Abu-Hamdan D. K., Migdal S. D., Prasad A. S., McDonald F. D., Elevated plasma copper in chronic renal failure. American Journal of Clinical Nutrition 1988 47 5 896 899 2-s2.0-0023906649
69. Ashok K. J., Sajida M. P., Joseph S., Plasma ceruloplasmin in chronic renal failure patients undergoing haemodialysis. Journal of Clinical and Diagnostic Research 2010 4 1 2058 2060 2-s2.0-77649217163
70. Kiss J. E., Berman D., Van Thiel D., Effective removal of copper by plasma exchange in fulminant Wilson's disease. Transfusion 1998 38 4 327 331 2-s2.0-0031924780 (Pubitemid 28213586)
71. Vukelic J., Kapamadzija A., Petrovic D., Variations of serum copper values in pregnancy. Srpski Arhiv za Celokupno Lekarstvo 2012 140 1-2 42 46 10.2298/SARH1202042V
72. Iseminger C. V., Anderson C. M., Johnson W. T., Placenta copper transport proteins in preeclampsia. Journal of Federation of American Societies for Experimental Biology 2010 24 609.5
73. Keen C. L., Uriu-Hare J. Y., Hawk S. N., Jankowski M. A., Daston G. P., Kwik-Uribe C. L., Rucker R. B., Effect of copper deficiency on prenatal development and pregnancy outcome. American Journal of Clinical Nutrition 1998 67 5 1003S 1011S 2-s2.0-0031981647 (Pubitemid 28198824)
74. Walker L. R., Rattigan M., Canterino J., A case of isolated elevated copper levels during pregnancy. Journal of Pregnancy 2011 2011 3 385767 10.1155/2011/385767
75. Crayton J. W., Walsh W. J., Elevated serum copper levels in women with a history of post-partum depression. Journal of Trace Elements in Medicine and Biology 2007 21 1 17 21 2-s2.0-33847055007 10.1016/j.jtemb.2006.10.001 (Pubitemid 46274255)
76. Duncan C., White A. R., Copper complexes as therapeutic agents. Metallomics 2012 4 2 127 138 10.1039/c2mt00174h
77. Dillon C. T., Hambley T. W., Kennedy B. J., Lay P. A., Weder J. E., Zhou Q., Copper and zinc complexes as antiinflammatory drugs. Metal Ions in Biological Systems 2004 41 253 277 2-s2.0-3042703858
78. Jiménez-Garrido N., Perelló L., Ortiz R., Alzuet G., González-Álvarez M., Cantón E., Liu-González M., García-Granda S., Pérez-Priede M., Antibacterial studies, DNA oxidative cleavage, and crystal structures of Cu(II) and Co(II) complexes with two quinolone family members, ciprofloxacin and enoxacin. Journal of Inorganic Biochemistry 2005 99 3 677 689 2-s2.0-13844298758 10.1016/j.jinorgbio.2004.11. 016 (Pubitemid 40247861)
79. Szczepanik W., Kaczmarek P., Jezowska-Bojczuk M., Oxidative activity of copper(II) complexes with aminoglycoside antibiotics as implication to the toxicity of these drugs. Bioinorganic Chemistry and Applications 2004 2 1-2 55 68 2-s2.0-38149092265
80. Correia dos Santos M. M., Famila V., Simões Gonçalves M. L., Copper-psychoactive drug complexes: a voltammetric approach to complexation by 1,4-benzodiazepines. Analytical Biochemistry 2002 303 2 111 119 2-s2.0-0037089561 10.1006/abio.2002.5580 (Pubitemid 34407574)
81. Okuyama S., Hashimoto S., Aihara H., Copper complexes of non-steroidal antiinflammatory agents: analgesic activity and possible opioid receptor activation. Agents and Actions 1987 21 1-2 130 144 2-s2.0-0023198910 (Pubitemid 17118317)
82. Salazar-Weber N. L., Smith J. P., Copper inhibits NMDA receptor-independent LTP and modulates the paired-pulse ratio after LTP in mouse hippocampal slices. International Journal of Alzheimer's Disease 2011 2011 10 864753 10.4061/2011/864753
83. Harris R. A., John Mihic S., Dildy-Mayfield J. E., Machu T. K., Actions of anesthetics on ligand-gated ion channels: role of receptor subunit composition. FASEB Journal 1995 9 14 1454 1462 2-s2.0-0028824297
84. Bousquet-Moore D., Ma X. M., Nillni E. A., Czyzyk T. A., Pintar J. E., Eipper B. A., Mains R. E., Reversal of physiological deficits caused by diminished levels of peptidylglycine -amidating monooxygenase by dietary copper. Endocrinology 2009 150 4 1739 1747 2-s2.0-63849187555 10.1210/en.2008-1202
85. Wu J., Ricker M., Muench J., Copper deficiency as cause of unexplained hematologic and neurologic deficits in patient with prior gastrointestinal surgery. Journal of the American Board of Family Medicine 2006 19 2 191 194 2-s2.0-33745906843 10.3122/jabfm.19.2.191 (Pubitemid 44046982)
86. Shander A., Javidroozi M., Ozawa S., What is really dangerous: anaemia or transfusion? British Journal of Anaesthesia 2011 107 supplement 1 41 59 10.1093/bja/aer350
87. Littlewood K. E., The immunocompromised adult patient and surgery. Best Practice and Research 2008 22 3 585 609 2-s2.0-49449117354 10.1016/j.bpa.2008. 05.005
88. Hebl J. R., Kopp S. L., Schroeder D. R., Horlocker T. T., Neurologic complications after neuraxial anesthesia or analgesia in patients with preexisting peripheral sensorimotor neuropathy or diabetic polyneuropathy. Anesthesia and Analgesia 2006 103 5 1294 1299 2-s2.0-33750327185 10.1213/01.ane.0000243384.75713.df (Pubitemid 44627362)
89. Schabel J. E., Subarachnoid block for a patient with progressive chronic inflammatory demyelinating polyneuropathy. Anesthesia and Analgesia 2001 93 5 1304 1306 2-s2.0-0034762696 (Pubitemid 33021038)
90. Hughes M., Grant I. S., Biccard B., Nimmo G., Suxamethonium and critical illness polyneuropathy. Anaesthesia and Intensive Care 1999 27 6 636 638 2-s2.0-0033396820 (Pubitemid 30021085)
91. Scurr C., Sampson B., Ball J., Gabriel C., Copper deficiency myeloneuropathy in a patient with haemachromatosis: a case report. Cases Journal 2009 2 8 6168 2-s2.0-77953471600 10.4076/1757-1626-2-6168
92. Sneyd J. R., Propofol and epilepsy. British Journal of Anaesthesia 1999 82 2 168 169 2-s2.0-0032907811 (Pubitemid 29057609)
93. Ramchandra D. S., Anisya V., Gourie-Devi M., Ketamine monoanaesthesia for diagnostic muscle biopsy in neuromuscular disorders in infancy and childhood: floppy infant syndrome. Canadian Journal of Anaesthesia 1990 37 4 474 476 2-s2.0-0025310466 (Pubitemid 20177112)
94. Plaud B., Meretoja O., Hofmockel R., Raft J., Stoddart P. A., Van Kuijk J. H. M., Hermens Y., Mirakhur R. K., Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology 2009 110 2 284 294 2-s2.0-61549120102 10.1097/ALN. 0b013e318194caaa